Incidence and risk factors for subcutaneous immunotherapy anaphylaxis: the optimization of safety.
about
Breathing Better Through Bugs: Asthma and the MicrobiomeA review of clinical efficacy, safety, new developments and adherence to allergen-specific immunotherapy in patients with allergic rhinitis caused by allergy to ragweed pollen (Ambrosia artemisiifolia).Effects of specific allergen immunotherapy on biological markers and clinical parameters in asthmatic children: a controlled-real life studyThe European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): A paediatric assessment.
P2860
Incidence and risk factors for subcutaneous immunotherapy anaphylaxis: the optimization of safety.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Incidence and risk factors for ...... s: the optimization of safety.
@en
type
label
Incidence and risk factors for ...... s: the optimization of safety.
@en
prefLabel
Incidence and risk factors for ...... s: the optimization of safety.
@en
P2093
P2860
P1476
Incidence and risk factors for ...... s: the optimization of safety.
@en
P2093
Anna Rita Dama
Gianenrico Senna
Ivana Djuric
Marcello Montagni
Marco Caminati
Michele Schiappoli
P2860
P304
P356
10.1586/1744666X.2015.988143
P577
2014-12-06T00:00:00Z